National Breast Cancer Coalition National Breast Cancer Coalition Fund

2005 Annual Report say it. fight it. cure it. stop it.

National Breast Cancer Coalition  NATIONAL BREAST CANCER COALITION FUND

The National Breast Cancer Coalition is a grassroots membership organization dedicated to ending breast cancer through the power of action and advocacy. Along with its research and education arm the National Breast Cancer Coalition Fund, the Coalition’s main goals are to increase federal funding for breast cancer research; improve access to high-quality health care and breast cancer clinical trials for all women; and expand the influence of breast cancer advocates wherever breast cancer decisions are made. Please visit www.stopbreastcancer.org for more information. Dear Supporter:

Power. Powerful. In 2005, NBCCF once again demonstrated what a powerful, committed group of trained advocates can do. We used the power of advocacy—patient- centered, evidence-based activism—to continue to revolutionize breast cancer research and access to care. And it is your support, your energy, your counsel, that provides the incredible strength we need to achieve our mission.

Your support gave us the power to reach out to opinion leaders and the media to keep the American public from drowning in the rhetoric of breast cancer awareness. We seem as a nation to be losing sight of the fact that 3 million women and several thousand men are living with this disease—and that more than 40,000 women died in the year 2005 alone. It is so important that we not get complacent, even as we celebrate a measure of progress in research and treatment.

And, as you will read in this report, our collective power got results. In spite of intense pressure to cut the federal budget, we were able to achieve a significant level of funding for the innovative Department of Defense Breast Cancer Research Program we spearheaded more than 10 years ago. NBCCF also took the lead in the promising new arena of biomarker research, convening a group of world-renowned experts to make sure that researchers focus on areas that will quickly prove useful to women with breast cancer. Hundreds of women and men attended our Annual Advocacy Training Conference with generous scholarship funding—and most stayed for an NBCC Lobby Day on Capitol Hill that included more than 420 visits with members of Congress and their key staff. And this year, thanks especially to a major outreach campaign in Latino communities, our Quality Care Initiative helped increase access to the best breast cancer treatment for everyone in this country.

A new source of NBCCF power comes thanks to former President Bill Clinton. He joined us at our annual New York gala to launch a new program within NBCCF, the Virginia Clinton Kelley Fund, in honor of his mother who died of breast cancer while he was in office. This innovative fund honors a strong, courageous woman, and will enable us to expand the bold strategies and creative approaches to ending this disease that have been our hallmark since our founding in 1991.

As we continue to lead a grassroots revolution in the world of breast cancer, I want to thank you for your support and the power it gives us to makes this non-stop, grueling, strategic, relentless work possible. We simply could not survive without you and your personal commitment to our mission—ending breast cancer, once and for all.

Be well.

Fran Visco President research

Revolution is not a one-time where such a diversity of scientific event, and the need for revolution disciplines—basic scientists, clinicians, in breast cancer research, one of the epidemiologists, nano-technologists, core reasons for NBCCF’s founding in mathematicians, physicists and more— 1991, takes enormous effort, focus and come together on an equal footing with courage. We were then, and remain consumers to look at the complexity now, focused on changing the prevailing of breast cancer research, challenge system of incremental, safe research that each other, explore controversial issues has more often than not produced little and learn and plan together. Thanks meaningful impact on women’s health. to NBCCF’s efforts, consumers play key roles in every aspect of the Era of The Department of Defense Breast Hope meeting. At the 2005 Era of Hope, Cancer Research Program is a direct controversial issues were confronted result of our 1992 campaign to head-on, and everyone was challenged dramatically increase federal funding to think in new ways. specifically targeted to innovative, multi-disciplinary, high-impact breast cancer research. It created and fosters an Biomarker Research unprecedented partnership that unites The use of biomarkers—measurable the military, scientific, medical and cellular or subcellular materials that breast cancer survivor and advocacy demonstrate the presence of malignancy communities to develop and carry or predict tumor behavior—is an area out research to end breast cancer. It is of promising research, and NBCCF once the federal government’s only breast again demonstrated its leadership by cancer research program that involves convening in November 2005 a Strategic consumer advocates at both the scientific Consensus Conference: Shaping the peer review and the programmatic Future of Biomarker Research to Ensure review stages, and it serves as a model of Clinical Relevance. transparency and accountability for all government programs. NBCCF trained advocates are highly engaged in every aspect of the DOD program. We are there to make certain that hard-fought research Thanks to NBCCF’s efforts, consumers dollars are well spent on important questions that will produce the answers play key roles in every aspect of the women with breast cancer as well as Era of Hope meeting. their families and friends demand and deserve.

Assembling a group of world-renowned Era of Hope researchers from government and An important part of the DOD initiative academia, FDA regulators, consumers, is the Era of Hope, a meeting designed clinicians and industry representatives, to report to the public on the research we focused on how biomarkers can be funded by the program. There may be no most useful in diagnosing and treating other forum in the scientific community women with breast cancer. Results

 national breast cancer coalition fund Carolina Hinestrosa, NBCCF executive vice president, programs and planning

Behind the Headlines The American public hears about important research chiefly through the popular media. Unfortunately, were beyond our expectations: a set of news articles sometimes include hype, five principles for a clinically relevant, exaggerations and errors that mislead collaborative and patient-centered women with breast cancer and others approach to conducting biomarker concerned about the disease. In our research. These principles serve as a Behind the Headlines program, we framework for the recommendations provide evidence-based analysis of developed by the conference panel. research studies, the facts, to better NBCCF will next mobilize to implement explain what the research actually means these in order to accelerate progress in for women with breast cancer. saving lives. From mammography to treatments NBCCF is grateful to the funders of for early breast cancer to the impact the biomarkers conference: the Regis of low-fat diets on breast cancer risk, Foundation for Breast Cancer Research, we analyze the studies and give the the Doris Duke Charitable Foundation, information individuals need to make Hurricane Voices and the Virginia decisions that will impact their lives. Clinton Kelley Fund. For example, when news stories created a misconception that digital mammography was generally superior Clinical Trials Initiative to traditional film mammography in detecting breast cancers we set the record Why a clinical trials program? Because straight. In fact, digital mammography NBCCF brings a unique patient does not detect more breast cancers in perspective to every aspect of the trials women over 50 years of age, the largest process. In 2005, we collaborated with group of women at elevated risk. While Allos Therapeutics on its ENRICH it does find more breast cancers among clinical trial, which is testing a drug younger women and women with dense to increase the efficacy of radiation for breasts, a much smaller group, we do not women with brain metastases. Another know if it actually saves lives. The media new NBCCF initiative is our work reports of this study created a false sense with the National Cancer Institute and of scarcity of the more expensive digital the North American Breast Cancer technology even though the population Intergroup on TAILORx, a trial to for whom a potential benefit was found determine whether a genomic test can is relatively small. Our website posting predict the response to chemotherapy explained the findings, encouraged among women with early breast cancer women to get more information before who are estrogen receptor positive coming to any premature conclusions and HER2-neu negative. This trial is and helped alleviate anxieties. important because if successful, it would help determine who is likely to benefit from chemotherapy and spare those who won’t from this harsh treatment.

2005 annual report  Access NBCCF’s Commitment to Many women feel overwhelmed and frightened when they are Quality Information and Universal diagnosed with breast cancer. In Access to Health Care order to provide the tools they need to take control of their NBCCF is committed to providing health care and make difficult evidence-based facts about breast treatment decisions, NBCCF cancer. Whether it is our position has produced a third edition about mammograms, or our belief in of our Guide to Quality Breast maintaining the integrity of drug clinical Cancer Care. Because we want trials, being true to that goal sometimes to reach the largest possible requires that we take unpopular audience, we have made it stands. Our integrity is our hallmark; available on our website. We it has earned NBCCF the unswerving also revised our short, easy-to-read respect of scientists, lawmakers, policy booklet How to Get Good Care for Breast experts and thousands of breast cancer Cancer. Both the English and Spanish survivors. versions are available at no cost by calling toll free 1-866-624-5307. To provide the best breast cancer information available, NBCCF this year developed new fact sheets and breaking news analyses. All of these were posted Personal Stories, Public Action™ to our website, www.stopbreastcancer.org. Campaign The topics ranged from gene profile “I am gratified that NBCCF wants testing to analysis of overall adjuvant to hear the personal stories…from treatment for women with HER2 women who … felt lost in the process positive early breast cancer. In addition of gaining information … or treated we updated our earlier position paper paternalistically by their physician.” indicatiing no link between abortion and —NBCCF Advocate breast cancer risk. Our members and the general public look to us for the truth Breast cancer is not an abstract about breast cancer and we continue to concept—it is a disease that affects each deserve their trust. individual in a different way, and with different impact on all aspects of life. In order to put a face on breast cancer for Our integrity is our policy makers and the broader health hallmark; it has earned care community, NBCCF continues to gather stories through our Stop Breast NBCCF the unswerving Cancer: Personal Stories, Public Action™ Campaign. We now have more than 600 respect of scientists, stories, from every state in the nation. lawmakers, policy experts They are helping NBCCF identify and better understand the real issues behind and thousands of breast the health care crisis and shape strategies for improvement through social and cancer survivors. political change.

 national breast cancer coalition fund Access

NBCCF advocates with our new exhibit at the San Antonio Breast Cancer Symposium

NBCCF In Action

NBCCF trains its advocates to be leaders whenever and wherever breast cancer decisions are being made. We have taken a seat at many decisionmaking tables, including:

• Department of Defense Breast Cancer • Institute of Medicine Committee on Research Program Integration Panel Improvements to Mammography • National Action Plan on Breast Cancer Quality Standards Act • President’s Cancer Panel • Institute of Medicine Roundtable on • National Cancer Advisory Board Evidence-Based Medicine • Association of American Medical • American Medical Association Ethical Colleges Task Force on Financial Force Conflicts of Interest in Clinical • The Breast Cancer and Environmental Research Research Centers • National Institute of Environmental • The Cochrane Collaboration Health Sciences Public Interest Consumer Coalition Committee • National Quality Forum, Breast • Breast Cancer International Research Cancer Technical Panel Group • Institute of Medicine Committee on • Institute of Medicine Clinical Research New Approaches to Early Detection Roundtable and Diagnosis of Breast Cancer • Markle Foundation, Connecting for Health, Personal Health Technology Program ...and more

2005 annual report  Influence Training the Breast Cancer Leaders Directed Medical Research Programs, spoke about the project’s enormous of Today and Tomorrow impact on the DOD Breast Cancer One of the hallmarks of NBCCF is Research Program. At a celebratory our commitment to train advocates to dinner, Dr. Andrew von Eschenbach, demand a seat at the table in all forums then director of the National Institutes of where research and health care decisions Health, praised the program as a model are made, and play an active role once of international standing in the research they are included. From our acclaimed community. science training course Project LEAD® through Team Leader Training, our in- During 2005, 106 advocates participated depth session on how to influence public in Project LEAD courses in Nashville, policy, to our Annual Advocacy Training Alexandria, Minneapolis and Conference, we offer both practical tools Washington. In addition, we held the and inspiration to the health care leaders second Quality Care Project LEAD pilot, of today and the future. bringing the number of breast cancer activists now trained to identify quality breast cancer care to 50. Project LEAD® NBCCF is grateful to the Avon “Advocates are very knowledgeable Foundation for its longstanding and about where we’re at and where we’re generous support of Project LEAD. going in research. They can discuss this on a personal level, on a human level, on a policy level and on a scientific level, given the success of Project Team Leader LEAD.” The goal of Team Leader Training is ­—Dennis Slamon, M.D., Ph.D., to build a cadre of informed volunteer UCLA School of Medicine, April, 2005 breast cancer activists, who are able to communicate about our legislative This year Project LEAD, NBCCF’s priorities to members of Congress and Advocates with then-NCI universally respected science their staffs, serve in a leadership capacity Director Dr. Andrew C. von and advocacy training program, and advocate for important breast cancer Eschenbach at the Project LEAD commemorated its 10th anniversary. To and other health policy issues in their 10th anniversary celebration mark this milestone, more than 200 of the program’s alumnae came together in Washington at the NBCCF Advocacy Conference. Faculty members presented updates on subjects such as the development of cancer at the molecular level, the structure and function of DNA, RNA and proteins, clinical trials and quality care. In addition, Col. Janet R. Harris, U.S. Army Medical Research and Materiel Command—Congressionally

 national breast cancer coalition fund NBCC advocate at the Annual Advocacy Influence Training Conference continuing to drive home fundamental skills, the agenda also added eleven new science and advocacy workshops, local communities. Team Leader consists displays highlighting the work of 15 of two days of training that include member organizations and dozens presentations, interactive sessions, group of distinguished speakers. After the role-play sessions and mock lobby day Conference ended, Lobby Day provided meetings with Capitol Hill staffers. These conferees the opportunity to have advocates will then take a leadership role meaningful conversations with their in NBCC’s annual Washington Lobby elected representatives and their staffs. Day event and lobby days as needed They left Washington inspired and throughout the legislative session, renewed, ready for another year of leading the meeting with their state fighting for change. representatives, senators and their staffs.

Annual Advocacy Sponsors Training Conference 2005 Annual Advocacy Training Conference Avon Foundation “We knew that we needed a revolution Project LEAD® 10th Anniversary Symposium to accomplish our mission. To examine this revolution, we first need to recognize Principal Underwriters Bristol-Myers Squibb that there are two types of advocacy: sanofi-aventis individual, where you decide to help one person or community to raise money Underwriters Eli Lilly and Company for one scientist or institution; or system Ortho Biotech advocacy, where you create systems of access to care that help thousands and Benefactors funding for the worldwide scientific Amgen Genentech community, setting an overall research Novartis agenda ... [As] NBCC activists, we focus Roche on the second —on changing the systems Patrons of research and care. And that advocacy AstraZeneca is extraordinarily difficult … we cannot Entertainment Industry Foundation afford to be anything less than leaders in Merck & Co. our mission to end breast cancer. “ Donors —Fran Visco, May, 2005 Affymetrix Genomic Health NBCCF’s 13th Advocacy Training Conference drew more than 600 Contributors Allos Therapeutics, Inc. participants from around the country, Barr Laboratories and the world, generating much Cytyc LP excitement about Fran Visco’s call for a Supporter breast cancer revolution to make sure AB Data, Inc. that the right research is funded. While

2005 annual report   national breast cancer coalition fund NBCCF advocates enjoy the Annual Advocacy Training Conference

2005 annual report  events Advocacy in Action Golf Classic NBCCF’s Advocacy in Action Golf Classic at the Tournament Players Club at Avenel near Washington, DC, featured players from the Women’s Futures Tour, a visit from Miss USA Chelsea Cooley and some tough competition. Shown left is Barr Laboratories CEO Bruce Downey kicking off the event.

Congressional Award Reception NBCCF honored Rep. Anna Eshoo at a March 10th event at the Washington home of Bobby Juliano. Several of her colleagues joined in the celebration of her commitment to ending breast cancer: (left to right) Representatives Anna Eshoo and Lois Capps, Fran Visco, Rep. George Miller, and House Minority Leader Nancy Pelosi.

Insiders’ Briefing on Breast Cancer and Women’s Health Care Policy

Senator Hillary Clinton joined more than 100 NBCCF members and friends at the home of Katja Goldman and Michael Sonnenfeld on March 4th in New York for a spirited discussion of women’s health issues.

She is shown left with host committee members Carol Wall and Dorian and Katja Goldman.

10 national breast cancer coalition fund Brenda Strong, Ricardo Antonio Chavira, Peri Gilpin and Felicity Huffman

Les Girls Cabaret On Monday, October 17 more than a dozen stars from the entertainment industry donated their time to NBCCF’s fifth annual Les Girls Cabaret at the Avalon Hollywood in Los Angeles. Attendees enjoyed lively and humorous song and dance routines performed by some of Hollywood’s most popular television and movie personalities.

Eric McCormack

2005 annual report 11 events Virginia Clinton Kelley Fund and Two outstanding grassroots advocates, both trained to lead teams of NBCC the New York Gala members to lobby for breast cancer NBCCF’s 2005 New York Gala included research funding on Capitol Hill, were a very special feature, former President honored at the event: Sandra Dave, who Bill Clinton’s launch of The Virginia continued her NBCC activism even Clinton Kelley Fund within NBCCF. while repairing her home damaged This program pays tribute to a woman by Hurricane Katrina, and Jennifer whose life exemplified the vision Levinson, who serves as a mentor for and strength to overcome seemingly many young survivors. insurmountable odds to achieve her goals and embodied the grassroots spirit of the National Breast Cancer Coalition Fund. The Virginia Clinton Kelley Fund will support NBCCF programs, which educate and train breast cancer survivors to influence research and public policy, foster innovation in research and health care and expand access to quality care. This fund will also support collaborations among women with breast cancer, researchers and health care stakeholders.

Revlon CEO Jack Stahl, Julianne Moore, President Clinton and Fran Visco

Amgen’s Rick Hertz and Kathryn West

Advocate Honorees Sandra Dave (front row, third from left) and Jennifer Levinson (second row, second from right) with NBCCF board members and friends

12 national breast cancer coalition fund events President Clinton and his mother

2005 annual report 13 NBCC THE NATIONAL BREAST CANCER This year we also made significant progress in moving forward the Breast COALITION Cancer and Environmental Research Breast cancer is more than a health issue. Act, a longtime NBCC priority. At our It is also a political issue that we can insistence, the bill was re-introduced at impact through public policy and public the beginning of the legislative session pressure. NBCC has led the way in this and quickly garnered strong bipartisan arena. We are not here just to make support: 62 co-sponsors in the Senate noise—though we certainly do make and 185 in the House in 2005, with more noise when the situation warrants. We added in early 2006. Our Congressional train breast cancer advocates to work Forums continued to educate Congress with our nation’s top decisionmakers on the importance of this policy. so they understand and act on our priorities, an agenda that is strategic and In 2000, NBCC led efforts to guarantee focuses on the real needs of women and that underserved women diagnosed men with breast cancer. with breast cancer, have access to a system of health care and get the Last year NBCC educated members of treatment they deserve. In 2005, we the congressional leadership that breast had to defend the Breast and Cervical cancer is not “taken care of,” and that it Cancer Treatment Program from severe is futile to fund window-dressing—pink Medicaid funding cuts. Thanks in part ribbon projects that will have no impact to our relentless work, the Medicaid on ending breast cancer—while denying cuts were reduced. Preserving the resources to serious programs. This funding for this program remains a high year, NBCC ’s advocates worked with priority for NBCC. lawmakers and staff to bring about genuine legislative accomplishment. The National Breast Cancer Coalition We succeeded, despite serious obstacles, embodies the power of responsible, in obtaining congressional approval meaningful advocacy—and, thanks of $127.5 million in funding for the to our powerful advocates, NBCC has Department of Defense peer-reviewed become a “household name”—in both Breast Cancer Research Program. Our houses of Congress. tenacity resulted in maintaining the strength of this innovative program.

The National Breast Cancer Coalition is NBCCF’s sister grassroots organization, dedicated to ending breast cancer through the power of action and advocacy.

14 national breast cancer coalition fund NBCC

Iowa advocate explains NBCC’s agenda to Rep. Tom Latham (R-IA)

New York advocates discuss NBCC’s legislative priorities with Sen. Charles Schumer (D-NY)

Sen. Lincoln Chafee (R-RI) with NBCC board Rep. John Murtha (D-PA), accepts an award member Marlene McCarthy from NBCC

2005 annual report 15 in the news MAMM Magazine Philadelphia Daily News September/October 2005 October 19,2005 “We cannot afford to leave the decisions to policy makers, scientists, “I think people feel that [breast cancer is] health-care providers or industry. taken care of. Because [there is]…such a We must be the leaders in our mission pleasant spin on it, this pink spin, to end breast cancer.” that people think there’s all this —Fran Visco awareness. We have a lot of awareness; we need action.” ­—Fran Visco The Washington Post September 16, 2005 The Boston Globe “I think it is very misleading to tell people that digital mammography is October 31, 2005 a better alternative to conventional “We’ve had more than 10 years of breast mammography. We don’t know that cancer awareness months, yet. Catching more cancers doesn’t and we still don’t know what necessarily mean you’re going to avoid causes breast cancer; we don’t more deaths from breast cancer… know how to cure it, and we can’t You just may be seeing cancer sooner, prevent it. Studies suggest the so that for a longer period of time environment plays a role, but we you have cancer but you aren’t lack a national strategy that asks affecting progression.” the right questions.” ­—Carolina Hinestrosa —Carol Matyka NBCCF executive vice president NBCCF field coordinator

CNN.com February 24, 2005 “Without question, people fear “Breast cancer is the disease that, for a long time, women feared the most…We cancer. It seems to be so random. tie femininity to physical appearance, and people think primarily of breast People will naturally want to do cancer that threatens your breasts— everything they can to avoid it, and though those who have it realize, more significantly, that it threatens your life.” that makes them vulnerable to all —Fran Visco sorts of unsavory marketing ploys.”

­—Carolina Hinestrosa, NBCCF executive vice president The Baltimore Sun, March 3, 2005

16 national breast cancer coalition fund in the news

On April 27, 2005, NBCCF President Fran Visco and Cynthia Pearson, NBCCF board member and executive director of the National Women’s Health Network (center), joined The New York Times science reporter Gina Kolata (right) as part of the New York Times’ Times Talks series. The subject of the discussion was “Taking Control of Your Health: What Can You Believe?”

Pittsburgh Post-Gazette Fort Worth Star-Telegram November 16, 2005 December 19, 2005 “I think women understand that what we’re “The worst piece of advice I ever got was, talking about here is a reduction in risk; ’Just listen to your doctor and do what she we’re not really talking about absolutely tells you.’ I needed to do my own research preventing a disease…Without question and talk to people who’d been through it.” [drug trials] are helping us learn more —Fran Visco about benefit and risk. Women are learning more about these issues and discussing them with their doctors. I think that’s a CBS News Sunday Morning very good thing.” —Fran Visco November 13, 2005 “As soon as we make investigational drugs available to people outside of clinical trials, fewer people will want to enroll in trials. The focus will be on making certain more and more people have access to those investigational, unproven, drugs just based on false hope.” ­—Fran Visco

2005 annual report 17 2005 financials

Statement of Financial Position

Assets 2005 2004 Cash & Cash Equivalents $98,660 $180,967 Accounts Receivable $1,608,872 $454,386 Grants Receivable - - Prepaid Expenses $ 46,650 $ 22,474 Investments $209,123 $205,654 Property & Equipment (net) $146,651 $189,647 Deposits $38,167 $43,689

TOTAL ASSETS $2,148,123 $1,096,817

Liabilities Current Liabilities $765,036 $620,351 Other Liabilities $15,386 $15,386

TOTAL LIABILITIES $780,422 $635,737

Net Assets Unrestricted $128,508 $322,090 Temporarily Restricted $1,239,193 $138,990

TOTAL NET ASSETS $1,367,701 $461,080

TOTAL LIABILITIES & NET ASSETS $2,148,123 $1,096,817

Statement of Activities 2005

Public Support & Other Revenue Expenses Donations $3,975,024 Program Services $3,728,076 Special Events (Net) $1,178,320 Management & General $307,657 Rental Revenue $94,162 Fundraising $356,453 Conference Registration $26,460 Total Expenses $4,392,186 Interest & Other Revenue $24,841

Total Revenue $5,298,807 Change in Net Assets $906,621

Net Assets Beginning of Year $461,080

Net Assets End of Year $1,367,701

18 national breast cancer coalition fund financials Public Support & Other Revenue 2005

Expenses 2005

2005 annual report 19 Corporate & Foundation donors $1,000,000 & above Nielsen Entertainment Williams and Connolly, LLP Novartis Oncology Winston and Strawn, LLP Avon Foundation Ropes & Gray, LLP Ziffren, Brittenham, Branca, Fischer, Shanrene, Inc. Stiffleman & Cook, LLP Skadden, Arps, Slate, Meagher & $500,000 to $999,999 Flom, LLP Breast Cancer Fund of the National $5,000 to $9,999 Philanthropic Trust Aaliyah Memorial Fund $10,000 to $24,999 Allos Therapeutics, Inc. Abbott Laboratories AT&T $100,000 to $499,999 Active Concepts, LLC Bank of America Active Media Services Inc Bloom, Hergott, Diemer, Rosenthal & Amgen Affymetrix Laviolette, LLP Bristol-Myers Squibb Company AstraZeneca Pharmaceuticals, LP California Teachers Association Genentech, Inc. AT&T Community Giving Program CBS/Paramount Television/UPN The Joyce and Irving Goldman Barr Laboratories City National Bank Family Foundation Bear, Stearns & Co. Inc. DPR Construction Inc. sanofi-aventis US, Inc. The Broder Webb Chervin Eichleay Engineers Inc. of California Vance Wall Foundation Silbermann Agency Endeavor Carat USA The Sol Goldman Charitable Trust Citigroup Global Market, Inc. Guckenheimer Enterprises, Inc. $50,000 to $99,999 The Clark Charitable Foundation Hathaway Dinwiddie Construction Condé Nast Publications Company Eli Lilly and Company Credit Suisse First Boston, LLC Hurricane Voices Breast Cancer Entertainment Industry Foundation Disney Worldwide Services, Inc Foundation Johnson & Johnson DOC Optics Corporation Kirkland and Ellis Foundation The Karan-Weiss Foundation Fleishman-Hillard, Inc. Kobo Products, Inc. Perelman Family Foundation, Inc. GCI Group Mayne Pharma Revlon Genomic Health, Inc. Muscular Therapy Clinic & Strong Revlon Group Foundation, Inc. Hard Rock Cafe Foundation, Inc. House Spa, Inc. Time Warner, Inc. Hearst Magazines North Star Gay Rodeo Association The Marilyn and Jeffrey Katzenberg Paradigm Foundation Shapiro Cohen $25,000 to $49,999 KPMG, LLP Spectrum Science Communications American Express Foundation Linear Technology Corporation The Joseph L. and Marjorie S. Barnes and Noble College LORAC Cosmetics, Inc. Steiner Foundation Booksellers, Inc. Merck & Co., Inc. Sterne, Kessler, Goldstein & Fox, PLLC The Clinton Family Foundation Mylan Laboratories, Inc. UBS Financial Services, Inc. Cytyc, LP Natexis Banques Populaires United Talent Agency Foundation Display Producers Inc. National Basketball Association United Way of Southeastern Generic Pharmaceutical Association Newman’s Own, Inc. Pennsylvania Giorgio Armani Sancoa International Warner Bros. Entertainment, Inc. The Kaplan Thaler Group Ltd. Science of Skincare, LLC Wells Fargo Bank Mellam Family Foundation Streisand Foundation Zoom Media Valassis Giving Committee

20 national breast cancer coalition fund donors $2,500 to $4,999 Capital Printing Systems Pyramid Printing & Graphics The Cheeryble Foundation Rand Construction Arnell Group, Ltd. CLK Management Corp RealNetworks Breast Cancer International Research Cohen Lans, LLP Rolling Terrace Elementary School Group Computer Associates Ross Family Fund Bunim-Murray Productions DDB Issues and Advocacy Schwab Fund For Charitable Giving Cohen, Pontani, Lieberman & Pavane Doe’s Famous Eat Place, Inc. SunTrust Robinson Humphrey Engelhard Corporation Earth Spectrum Synergos Institute Fidelity Investments Charitable Albert Einstein Cancer Center T.I.P. Educational Fund Gift Fund Family Management Corporation The TR Family Trust Friedman, Billings, Ramsey & Co. Fitzpatrick, Cella, Harper & Scinto Turnaround Mangement Association Gedeon Richter USA, Inc. Fougera, Inc. United Way of Kitsap County Gucci Friends and Fans of Lauren Graham Virginia Breast Cancer Foundation Icare Gary & Diane Heavin Community The Westport Fund Abe & Frances Lastfogel Foundation Fund, Inc. Wolfensohn Family Foundation Lifetime Television Georgia Breast Cancer Coalition Fund Women of Color Breast Cancer Survivors Lipo Chemicals Inc Graff Valve & Fittings Company Support Project McCarthy Building Companies, Inc. Grant, Tani, Barash & Altman, LLC World Reach, Inc. Mercer Human Resource Hansen, Jacobson, Teller, Hoberman, Y-Me National Breast Cancer Consulting, Inc. Newman, Warren and Richman, LLP Organization, Inc. New Hampshire Breast Cancer Harris Marketing Group Young Survival Coalition Coalition The Hauptman Family Philanthropies Yum! Brands Foundation, Inc. Par Pharmaceutical Companies, Inc. Honeywell Zuckerman Spaeder, LLP Plantex USA, Inc. Inamed Aesthetics The Rhode Island Breast Cancer Jason Natural Cosmetics Coalition Jewish Communal Fund Sandoz Kanye Foundation Sears The Mayer & Morris Kaplan Family Service Employees International Foundation Union Kentucky Cancer Program Martha Stewart Living Latina Omnimedia, Inc. Maine Breast Cancer Coalition Teva Pharmaceuticals McMullen Family Foundation Webster Fredrickson & Brackshaw Microsoft Zissu Family Foundation Montclair State University National Analysts, Inc. National Comprehensive Cancer Network $1000 to $2,499 NBC West, Inc. News America Marketing AB Data, Inc. The New York Community Trust Alamo Breast Cancer Foundation Pacific Maintenance Company Art BeCAUSE Foundation Paul, Weiss, Rifkind, Wharton & Best Life Garrison, LLP Bratskeir & Company Inc. Poulos Brothers Breast Cancer Alliance of Greater Public Affairs Associates, LLC Cincinnati

2005 annual report 21 Individual donors $10,000 & above Thomas W. Hildreth Bernice Manocherian Constance and Donald Jones Lorree McBride and Brent Spiner Susanna Lachs Adler Ethel Klein Doris L. Rickard Cynthia and Robert Broder Peter Kraus Carole Rose Jan R. Cloyde David Lee Beth and David Rothenberg Camille and William Cosby Krista and Steve Levitan Helen Schiff and Richard Congress Alisa and Daniel Doctoroff Carol and Stu Lystad Allison R. Schneirov and Steven L. Susan Greendale Barbara Matas Fisch Thomas R. Kline Catherine Meek and Al Earle Gail and Steven Shak John Mahoney Christine and Dermod Norton Mace Siegel Lauralee and Scott Martin Norma and Norman Nutman Carl Spielvogel Musa and Thomas Mayer David Hyde Pierce Nicki and Harold Tanner Melinda and Scott Nordeng Rosemary Rosso Marjorie K. Taylor Claudia and Daniel Placentra Scott M. Sampson Judith H. Tuller Michele Rakoff and Alan Sieroty Arlene Sanford Kathryn Vashro Arleen F. Sorkin and Christopher Elizabeth H. Scheuer and Peter Joseph Karen and John Walker Lloyd Marc Shaiman and Scott Wittman Cliff Watts Fern and Lenard Tessler Elana Solomon Carol and Michael Weisman Samuel D. Turner Frances M. Visco and Arthur Sandra K. Westfall Carol and Harlan Waksal Brandolph Carol Wall Todd R. Wagner Ann C. Yahner $1000 to $2,499 $2,500 to $4,999 Lynda Abdoo $5,000 to $9,999 Sandra A. Adams and Tom Roberts Elizabeth and Richard Berman Carole and Jerre Allen Madeline Anbinder Vernal H. Branch Carol Altarescu Anonymous Elaine Laskin-Broida and Michael Betty Altman Norma K. Asnes Broida Susan and Robert Appleton Judi J. Hirshfield-Bartek and Elmer Richard Cassese Joan Arnow Bartek Diane and Alan Chase Kathleen M. Ball Gerry Bernardi and Joe Keenan Jill Chayet Joan and Kenneth Barrett Susan and David Bershad Jan and Harry Cohen Carmen and Yogi Berra Pamela and Roger Birnbaum Linda M. Correia Suzanne and Donald Bezahler Franci J. Blassberg James Derderian Shirley Bilek Kimberly C. Blum Judy Dering and Frank Calzone Robin and Elliott Broidy Bobbi Brown and Steven Plofker Ruth G. Eldredge Patricia S. Brown† Judy and Nicholas Bunzl Ellen Elkind Bettina and Bruce Buschel Debbie and James Burrows Patricia L. Freysinger Julia A. Byers Trisha Cardoso Karren Ganstwig Philip E. Cable Gia Carides and Anthony Lapaglia Sara Gottesman Richard A. Carnevale Rosemary and Peter Casey Cathie and Roger Hogan Faya Causey Glen Charles Rosemary and Alfred Iversen Harriet S. Chalfant† Susan DiMarco and Jeh Johnson Jean Jackman Ulrika and Joel Citron Keith Dodd and John Pettiette Karen Jacobson Susan Cohen-Hevrony Dorothea and Peter Frank Ethel Klein Henry Cornell Tom Henri Galit and Scott Kursman Judith Crown Craver

22 national breast cancer coalition fund donors

Louise Danelian Nancy E. Kahn Janice Rosenhaus Kay Dickersin and Robert Van Wesep Curt Kaplan Lyn and George Ross Margaret Dulany Marie and Jeffrey Kaplan Merry B. Ross and Patrick Zimski Kathryn Duva Roberta A. Kaplan Toni L. Ross Kathleen Dwyer Marianne Karmel Richard Rothenberg Sarah Sapir Eisen F. Alexandra Klas Nancy A. Ryan Carol A. Evans Helen Kornblum Jill Schehr Sacks Linda and David Evans Sarah S. Kovner John M. Sakamoto Susan and Ed Falk Harvey D. Kushner Rae Sanchini and Bruce Tobey Leah and Samuel Fischer Rosetta Lane Miriam A. Schneirov Miriam and Ralph Freiden Diane S. Langley Victoria E. Schonfeld Rochelle and Robert Friedman Patricia and Philip Laskawy James C. Schultz Rebecca Fry Leona and Meyer Laskin Christopher J. Schwab Betsy and Don Garber Sheree Lennard Janice Shand Judith Garson and Steven Rappaport Janet Lerman-Graff Ann and Stephen Shapiro Catherine T. Gatto-Harding Jerry W. Levin Donna Shelley Jami Gertz and Tony Ressler Paula Levine Gertrude Shelley Nomi P. Ghez and Michael Siegal Karen and Franklin Lewkowitz Tobyanne and Arnold Sidman Gail Gillespie and Dwight Rogers Nancy Lisagor Muriel F. Siebert Hazel Gluck Shelley and Frank Litvack Lyn and David Silfen Wendy and Fred Goldberg Marilynn Mack Joy A. Simha and Vasudev Sudarsana Dorian S. Goldman and Marvin Suzanne J. Marks Leslie and Adam Small Israelow Frank J. Martone Shirley Small Harriet and David Goldman Marlene and Joseph McCarthy Kathleen Smith Karen and Russell Goldsmith Diane E. McGarry Michelle Smith and Andrew Oshrin Ann Gottlieb Pamela McGreevy William E. Spencer Anne and George Grant Kevin S. McGuiness Sandra L. Spivey Fabian Guerin Renee and David McKee Susan and Jeffrey Stern Jody Gunn Muffie Meier Heidi and Thomas Stever Claudette Gurley Shelley Meltzer Daily Susman Kathleen and Arthur Harris Joyce and Robert Menschel Sharon and Patrick Terry Patricia K. Haugen Christine M. Millen Susan Thomson Wayne H. Heldt Arthur H. Moore Marilyn and Thomas Trienens Martha Henderson Patricia A. Mulcahy Lisa Y. Tung and Spencer P. Glendon Jeanne and Richard Hersh Maureen A. Murray Maria T. Vullo Susan R. Hester Eugene Nesbit Judy and Josh Weston Becky Hettinger Christie and Edwin Neuger Anne and Alexander White Hildy and Walter Hill Gayle A. Nobbs Diane B. Wilsey M. Carolina Hinestrosa John Norwood Kathleen Zeitz Ruth Israelow Karin Decker Noss Donald Zief Lorre Lei and John Jackson Randy Osofsky Linda and Jeffrey Zissu Deanna W. Jensen Olga Paulson G. Owen Johnson Adriana Pope Sullivan Karen A. Johnson Linda Rabbitt and John Whelan Lisa J. Jorgenson and David D. Maurice Reder Doniger Rachel and Seth Ringler Jane Kaczmarek Sandra Rosenbaum

† deceased

2005 annual report 23 Board of directors

Adelphi NY Statewide Breast Cancer Hotline Metropolitan Washington, DC Chapter of NBCC and Support Program Christine Brunswick Marie Kaplan Alternate: Rosemary Rosso Alternate: Hillary Rutter Minnesota Breast Cancer Coalition African-American Women in Touch Christine Norton Bettye Green Alternate: Carolyn DeArmond National Breast Cancer Coalition Frances M. Visco Alamo Breast Cancer Foundation Dale Eastman National Women’s Health Network Alternate: Joy Moose Cindy Pearson Alternate: Amy Allina Association of Women’s Health, Obstetric and Neonatal Nurses Nueva Vida Melinda Mercer Ray Larisa C. Caicedo Alternate: Karen Peddicord Alternate: Mary Jo Vazquez

Breast Cancer Alliance of Greater Cincinnati The Revlon/UCLA Breast Center Kathy Ball Sherry Goldman Alternate: Ann Hernick Alternate: Janice Boron

California Breast Cancer Organization Rhode Island Breast Cancer Coalition Sandy Walsh Marlene McCarthy Alternate: Michele Rakoff Alternate: Jean Albert

Georgia Breast Cancer Coalition Fund SHARE Ruth Eldredge Anne Grant Alternate: Chara Jackson Alternate: Ivis Febus-Sampayo

Hadassah, the Women’s Zionist Dr. Susan Love Research Foundation Organization of America Susan Love, M.D. Doris W. Greenberg Alternate: Judi Hirschfield-Bartek Alternate: Marla Gilson Virginia Breast Cancer Foundation Kentucky Cancer Program Karin Noss Harriet Chalfant Alternate: Barbara Dittmeier Alternate: Connie Sorrell Women of Color Breast Cancer Survivors’ Linda Creed Breast Cancer Foundation Support Project Donna Duncan Shirley Brown Alternate: Linda Camerota Alternate: Carolyn Tapp

Louisiana Breast Cancer Task Force Y-Me National Breast Cancer Organization Lorre Lei Jackson Margaret Kirk Alternate: Diane Ferguson Alternate: Kay Wissmann

Mautner Project for Lesbians with Cancer Young Survival Coalition Kate McQueen Joy Simha Alternate: Kathleen DeBold Alternate: Elizabeth Wohl

24 national breast cancer coalition fund 2005 annual report  1101 17th St., NW, Suite 1300, Washington, DC 20036

toll free: 800.622.2838 phone: 202.296.7477 fax: 202.265.6854 www.stopbreastcancer.org

“I remember when you couldn’t even say breast, let alone breast cancer. Women did not say those words. That has changed quite a bit.”

—Fran Visco, NBCCF president, CNN.com, February 24, 2005

1101 17th St., NW, Suite 1300, Washington, DC 20036

toll free: 800.622.2838 phone: 202.296.7477 fax: 202.265.6854 www.stopbreastcancer.org